Health Care · Services-Misc Health & Allied Services, NEC · Nasdaq · CIK 1505497 · FYE Dec 31 · Prices AT CLOSE 2026-07-30 (USD) — end-of-day, never a live or intraday quote
Last $0.23Day −8.74%Mkt cap $6M1Y −84.8%Off 52W high −88.1%Vol (1Y) 141.4%
Daily closing price, split-adjusted to the current basis; 3y shown of 1,233 bars on file. Sampled to 240 points — every point is a real close, none averaged. Price return, not total return (dividends excluded). Source marketstack.
| Short interest3.0% of sh out |
| Days to cover2.6d |
| 13F net flow (QoQ)+1.47% |
| Top-10 13F concentration100.0% |
| Next report (est.)2026-08-13 |
Short interest is FINRA semi-monthly, settlement 2026-07-15. 13F figures are quarterly filings, period 2026-Q1 — a lower bound on true ownership.
| Sales (TTM)$357,870 |
| Earnings (TTM)-$11.1M |
| ROE−320.5% |
| Net margin−3959.4% |
| Sales growth 3Y44.3% |
Screener basis: ratios from the latest reported fiscal year; Sales/Earnings are trailing twelve months in the reporting currency (USD). The P/E is a trailing FULL-YEAR P/E, not TTM. Missing lines are absent from the filings, never imputed.
| YTD−80.8% |
| 1Y−84.8% |
| 3Y−92.2% |
| 5Y−98.8% |
| Since incept. (ann.)−65.0% |
Total return through 2026-07-30 · series begins 2021-02-22. Only the windows this history actually covers are shown.
| Ann. volatility (1Y)141.4% |
| Ann. volatility (3Y)113.5% |
| Sharpe (1Y)−0.67 |
| Sharpe (3Y)−0.18 |
| Max drawdown (1Y)−90.8% |
| Max drawdown (3Y)−95.1% |
| Beta (3Y vs SPY)1.36 |
Daily simple returns, annualized; drawdown is peak-to-trough within the window. Beta is the OLS slope of monthly returns on SPY's over three years. Each figure is labeled by the window it was measured over — they are not comparable across windows.
| Manager | Shares | Value | % sh out | QoQ |
|---|---|---|---|---|
| CITADEL ADVISORS LLC | 238,606 | $64,925 | 0.94% | +717.2% |
| GEODE CAPITAL MANAGEMENT, LLC | 223,083 | $60,700 | 0.88% | +285.6% |
| UBS Group AG | 99,832 | $27,154 | 0.39% | new |
| WEALTH ALLIANCE, LLC | 40,000 | $10,884 | 0.16% | +0.0% |
| VANGUARD FIDUCIARY TRUST CO | 39,452 | $10,731 | 0.15% | new |
| STATE STREET CORP | 32,459 | $8,832 | 0.13% | +0.0% |
| OSAIC HOLDINGS, INC. | 2,000 | $540 | 0.01% | +0.0% |
| Tower Research Capital LLC (TRC) | 1,462 | $398 | 0.01% | +32.2% |
Reported 13F long positions as filed for 2026-Q1 (change vs 2025-Q4). 13F covers US-listed long equity only — the sum is a LOWER BOUND on institutional ownership, never a total.
| Period end | Reported | EPS | EPS YoY | Revenue | Rev YoY |
|---|---|---|---|---|---|
| 2026-03-31 | 2026-05-14 | −$0.12 | — | $23,170 | −7.3% |
| 2025-12-31 | 2026-03-26 | — | — | $19,600 | −54.7% |
| 2025-09-30 | 2025-11-12 | −$0.33 | — | $11,800 | −94.9% |
| 2025-06-30 | 2025-08-12 | −$0.30 | — | $303,300 | +240.4% |
EPS and revenue as reported in this filer's own XBRL — our extraction of the filings, not a vendor consensus feed, and never a beat/miss claim (we carry no estimates). YoY compares the same fiscal quarter a year earlier. Next report 2026-08-13 is ESTIMATED from filing cadence (median gap 91d) — not company-confirmed.
Product 83% · Royalty 17%
product & service · each slice's share of TAGGED segment revenue in the latest annual filing (XBRL, as filed). Untagged revenue is excluded from the denominator, so slices need not sum to consolidated sales.
